Early FDG PET/CT Imaging for Predicting Response to Pembrolizumab in Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma
Clin. Cancer Res 2024 Jan 24;[EPub Ahead of Print], TM Anderson, BH Chang, AC Huang, X Xu, D Yoon, CG Shang, R Mick, E Schubert, S McGettigan, K Kreider, W Xu, EJ Wherry, LM Schuchter, RK Amaravadi, TC Mitchell, MD FarwellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.